Navigation Links
COMBACTE: A new step in the fight against resistance to antibiotics
Date:2/26/2013

The COMBACTE (Combatting Bacterial Resistance in Europe) project, resulting from the sixth Call for proposals issued by the IMI, is one of the projects that is part of the "New Drugs For Bad Bugs" (ND4BB) programme. It is the result of the initial association between industry and two academic consortia, the Eu-ACT and INCRAID, run respectively by Marc Bonten of the University of Utrecht and Bruno Franois of Limoges University Hospital, both being responsible for overall project coordination along with representatives of the EFPIA, Scott White (GlaxoSmithKline) and Seamus O'Brien (Astra Zeneca).

The project will last for seven years and will bring together about 20 partners from all over Europe. It is designed to generate innovative trials to facilitate the registration of new anti-bacterial agents, mainly through the creation of a network of experienced investigators. It will also design and validate tests to support the diagnosis of patients, identify the most suitable treatments and monitor the treatment response.

Much of the project will be devoted to performing clinical trials of anti-infectious medication currently being developed by the pharmaceutical companies involved in the programme. The first antibiotic to be subjected to clinical trials under the COMBACTE programme has been developed by GlaxoSmithKline's laboratories.

For these purposes, the total budget for the COMBACTE project amounts to nearly 195 million euros, a scale of finance hitherto unequalled in private-public clinical research.

French partners in the European COMBACTE Project

Of the various partners, several French entities are involved in the COMBACTE project.

Dr Bruno Franois, under the aegis of Limoges University Hospital, will be responsible for coordinating the clinical trials in collaboration with all the European investigator centres and the GSK Group and GSK France (GSK Medical Management France) Research Groups. Dr Franois will also partic
'/>"/>

Contact: Elodie PFENDER
elodie.pfender@chu-limoges.fr
33-055-505-8837
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Scientists find bone-marrow environment that helps produce infection-fighting T and B cells
2. Compound stimulates tumor-fighting protein in cancer therapy
3. In a fight to the finish, Saint Louis University research aims knockout punch at hepatitis B
4. Planning for bacteria in cancer patients may help hospitals fight infections
5. La Jolla Institute identifies molecular switch enabling immune cells to better fight disease
6. New insights into how immune system fights atherosclerosis
7. University of Tennessee researchers find fungus has cancer-fighting power
8. Compound in grapes, red wine could be key to fighting prostate cancer
9. Immune system fighters speak in patterns of proteins, prefer squishy partners
10. Fighting melanomas attraction to the brain
11. An important breakthrough in the fight against muscular dystrophies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Minnesota Medical School researchers from the Masonic Cancer Center, ... Tumor Program, have developed a new mouse model of ... to discover new genes and gene pathways driving this ... week in the journal Nature Genetics . , ... lab of David Largaespada, Ph.D., professor in the Medical ...
(Date:5/20/2013)... ITHACA, N.Y. Little is known about the effect ... new study from Cornell University finds that increasing the ... class reduces the probability of obesity. , The study ... effect of PE on youth obesity, and is forthcoming ... An early, online version of the study can be ...
(Date:5/20/2013)... lungs of the planet, inhales carbon dioxide as it exudes ... parts that eventually fall to the ground to decompose or ... Until recently people believed much of the rain forest,s carbon ... the ocean. University of Washington research showed a decade ago ... left open the question of how that was possible, since ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2Gym class reduces probability of obesity, study finds for first time 2Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3
... farming and relieve the pressure on overexploited fish stocks. ... fish escape? Researchers at the University of Gothenburg have ... are urging caution:,-Until further notice transgenic fish should be ... at the Department of Zoology, University of Gothenburg. ...
... to the neotropicsthe tropical lands of the Americasmight be ... flittering over sunny puddles or among dense forest understory ... moths that have reinvented themselves as butterflies, converging on ... relatives. Now, a new revision of the taxonomic relationships ...
... Scientists have developed a new molecular sensor that can reveal the ... a number of diseases, including type 2 diabetes. The research, published ... hidden world of zinc biology by giving scientists an accurate way ... for the first time. Zinc is involved in many processes ...
Cached Biology News:Risks involved with transgenic fish 2Moths cloaked in color 2Moths cloaked in color 3Moths cloaked in color 4Think zinc: Molecular sensor could reveal zinc's role in diseases 2
(Date:5/20/2013)... 2013 Grace Century , an ... life science and health related private equity projects, has ... International Project Team. Dergham's expertise in finance and international ... to Grace Century as it continues to look at ... Dergham holds both an under graduate degree from the ...
(Date:5/20/2013)... May 20, 2013 Oven Industries Inc. ... ramp/soak capabilities. The 5R6-900 benchtop controller has many outstanding ... can be plugged into the wall as a self-contained ... This distinctive detail makes the device unique, as well ... laboratory temperature controller can also be used universally, which ...
(Date:5/20/2013)... KENNESAW, Ga. , May 20, 2013  MiMedx ... developer, manufacturer and marketer of patent protected regenerative biomaterials ... that it has secured a revolving line of credit ... facility, which is secured by the Company,s accounts receivable ... million through May 1, 2014.  The facility will be ...
(Date:5/20/2013)... 2013 Today, at the American Psychiatric Association ... James McGough , M.D., M.S., principal ... Institute for Neuroscience and Human Behavior and ... University of California Los Angeles (UCLA), and director of ... and ADHD at UCLA, presented the results of a ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
... NEWTON, Mass., March 31 Tryton Medical, Inc., ... treatment of,bifurcation lesions announced today that it has ... Two new investors, PTV Sciences and RiverVest Venture,Partners ... Rick Anderson,from PTV and Jay Schmelter from RiverVest ...
... ExonHit Therapeutics, a drug,and diagnostic discovery company, today announced ... Management Board on April 1st,2008. At the same date, ... a new CEO is appointed., Philippe Rousseau has ... been a member of its Management Board since 2004. ...
... Calif., March 31 BioMarin,Pharmaceutical Inc. (Nasdaq and ... BioMarin,s marketing and distribution partner in Japan, has,received ... the Japanese Ministry of Health, Labour and Welfare,(MHLW) ... ( MPS,VI)., "We are proud to work ...
Cached Biology Technology:Tryton Medical, Inc. Closes $14 Million Financing 2Tryton Medical, Inc. Closes $14 Million Financing 3ExonHit Appoints a New Management Board 2ExonHit Appoints a New Management Board 3ExonHit Appoints a New Management Board 4Naglazyme Approved by Japanese Ministry of Health 2Naglazyme Approved by Japanese Ministry of Health 3Naglazyme Approved by Japanese Ministry of Health 4
... Blue LED produces output at 470 nm; ... with an S2000 or installed into rack or ... Pulsed Light Source is an LED that produces ... -- the blue region -- for fluorescence measurements. ...
... XL extends the MSn performance of the ... tools to generate extensive structural information for ... , Multiple dissociation techniques (PQD, ETD, ... unpredicted metabolites , Fast polarity switching for ...
Request Info...
The Synergy HT utilizes a unique dual-optics design combined with monochromator wavelength selection to provide uncompromised performance in absorbance, fluorescence and luminescence reading modes. ...
Biology Products: